Instantaneous stroke risk assessment of adults in Enugu, South East Nigeria: results from a random point survey
Accepted: 12 December 2022
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Stroke remains a major cause of morbidity, death, and disability around the world, most especially in black Africans. Understanding the magnitude and appreciation of stroke risk in susceptible populations remains a key strategy in reducing stroke burden. This study examined and compared 5-year stroke risk in an adult population in Enugu, Southeast Nigeria. A point cross-sectional survey assessing stroke risk in adults was done in October 2019 in the city of Enugu as part of the World Stroke Day commemoration using the Stroke Riskometer app, and the data was analyzed. Ethical approval was obtained. The total number of participants in this survey was 117 traders in a market in the Enugu metropolis, Enugu State, Nigeria. More males, 63%, than females, 37%, participated in this study. The total mean age was 47.50 years, with a total mean 5-year stroke risk of 3.93. Stroke risk was noted to be higher in females 4.56 than in males 3.56. Elevated blood pressure was present in 35% of the participants, and elevated blood glucose was seen in 5% of the total population. The World Stroke Organization’s Stroke Riskometer app is a valuable tool in assessing stroke risks especially in resource poor settings. This app also serves as a cost-effective method of conducting epidemiological research in stroke and other non-communicable diseases internationally. Hypertension remains the most common risk factor for stroke globally. Higher stroke risk in females likely associated with higher mean age.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.